References
- Abe S, Takahashi H. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 1. Diffuse infiltrative lung disease – new clinical biomarker in diffuse interstitial pneumonia. Internal Medicine 2001; 40: 159–162
- Al-Salmi QA, Walter JN, Colasurdo GN, Sockrider MM, Smith EO, Takahashi H, Fan LL. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease. Chest 2005; 127: 403–407
- Behera D, Balamugesh T, Venkateswarlu D, Gupta A, Majumdar S. Serum surfactant protein-A levels in chronic bronchitis and its relation to smoking. Indian Journal of Chest Disease & Allied Science 2005; 47: 13–17
- Berthoin K, Broeckaert F, Robin M, Haufroid V, De Burbure C, Bernard A. Serum pneumoproteins and biomarkers of exposure to urban air pollution: a cross-sectional comparison of policemen and foresters. Biomarkers 2004; 9: 341–352
- Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y, Nishimura M. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. European Respiratory Journal 2004; 24: 964–970
- Celli BR, MacNee W, committee membersATS/ERS TASK FORCE. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal 2004; 23: 932–946
- Cheng G, Ueda T, Nakajima H, Nakajima A, Arima M, Kinjyo S, Fukuda T. Surfactant protein A exhibits inhibitory effect on eosinophils IL-8 production. Biochemical & Biophysical Research Communications 2000; 270: 831–835
- Greene KE, King TE, Jr, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, Nagae H, Mason RJ. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. European Respiratory Journal 2002; 19: 439–446
- Ishii H, Mukae H, Kadota J, Kaida H, Nagata T, Abe K, Matsukura S, Kohno S. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003; 58: 52–57
- Kuroki Y, Takahashi H, Chiba H, Akino T. Review. Surfactant proteins A and D: disease markers. Biochimica et Biophysica Acta 1998; 1408: 334–345
- McCormack FX. Structure, processing and properties of surfactant protein A. Biochimica et Biophysica Acta 1998; 1408: 109–131
- McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. Journal of Clinical Investigations 2002; 109: 707–712
- Mutti A, Corradi M, Goldoni M, Vettori MV, Bernard A, Apostoli P. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. Chest 2006; 129: 1288–1297
- Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. American Journal of Respiratory & Critical Care Medicine 2002; 165: 378–381
- Rabe KF, Hurd S, Anzueto A, , et al; Global Initiative for Chronic Obstructive Lung Disease. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory & Critical Care Medicine 176:532–555.
- Robin M, Dong P, Hermans C, Bernard A, Bersten AD, Doyle IR. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. European Respiratory Journal 2002; 20: 1152–1161
- Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. American Journal of Respiratory & Critical Care Medicine 2000a; 162: 1109–1114
- Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, Sagawa A, Nagae H, Abe S. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. American Journal of Respiratory & Critical Care Medicine 2000b; 162: 258–263
- Takahashi H, Shiratori M, Kanai A, Chiba H, Kuroki Y, Abe S. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11 (Suppl.): S51–S54
- Ueda T, Cheng G, Kuroki Y, Sano H, Sugiyama K, Motojima S, Fukuda T. Effects of aging on surfactant forms in rats. European Respiratory Journal 2000; 15: 80–84